| Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national … B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ... Clinical infectious diseases 46 (12), 1813-1821, 2008 | 5596 | 2008 |
| Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group … JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ... Clinical Infectious Diseases 71 (6), 1367-1376, 2020 | 1869 | 2020 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non‐neutropenic adult patients OA Cornely, M Bassetti, T Calandra, J Garbino, BJ Kullberg, O Lortholary, ... Clinical Microbiology and Infection 18, 19-37, 2012 | 1301 | 2012 |
| Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ... Clinical Microbiology and Infection 24, e1-e38, 2018 | 1274 | 2018 |
| Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae: Importance of Combination … M Tumbarello, P Viale, C Viscoli, EM Trecarichi, F Tumietto, A Marchese, ... Clinical infectious diseases 55 (7), 943-950, 2012 | 1125 | 2012 |
| Death and furniture: The rhetoric, politics and theology of bottom line arguments against relativism D Edwards, M Ashmore, J Potter History of the human sciences 8 (2), 25-49, 1995 | 1115* | 1995 |
| Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and … C Viscoli, C Girmenia, A Marinus, L Collette, P Martino, B Vandercam, ... Clinical infectious diseases 28 (5), 1071-1079, 1999 | 744 | 1999 |
| European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study … B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ... Clin Infect Dis 46 (12), 1813-1821, 2008 | 723 | 2008 |
| International consensus guidelines for the optimal use of the polymyxins: endorsed by the American college of clinical pharmacy (ACCP), European society of clinical … BT Tsuji, JM Pogue, AP Zavascki, M Paul, GL Daikos, A Forrest, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (1 …, 2019 | 693 | 2019 |
| ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients F Tissot, S Agrawal, L Pagano, G Petrikkos, AH Groll, A Skiada, ... haematologica 102 (3), 433, 2017 | 661 | 2017 |
| Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial BJ Kullberg, JD Sobel, M Ruhnke, PG Pappas, C Viscoli, JH Rex, ... The Lancet 366 (9495), 1435-1442, 2005 | 642 | 2005 |
| European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on … D Averbuch, C Orasch, C Cordonnier, DM Livermore, M Mikulska, ... haematologica 98 (12), 1826, 2013 | 604 | 2013 |
| Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study M Tumbarello, EM Trecarichi, FG De Rosa, M Giannella, DR Giacobbe, ... Journal of Antimicrobial Chemotherapy 70 (7), 2133-2143, 2015 | 570 | 2015 |
| Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy WV Kern, A Cometta, R De Bock, J Langenaeken, M Paesmans, G Zanetti, ... New England Journal of Medicine 341 (5), 312-318, 1999 | 490 | 1999 |
| Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of … BH Segal, R Herbrecht, DA Stevens, L Ostrosky-Zeichner, J Sobel, ... Clinical infectious diseases 47 (5), 674-683, 2008 | 480 | 2008 |
| Epidemiological trends in nosocomial candidemia in intensive care M Bassetti, E Righi, A Costa, R Fasce, MP Molinari, R Rosso, ... BMC Infectious Diseases 6, 1-6, 2006 | 476 | 2006 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures M Cuenca‐Estrella, PE Verweij, MC Arendrup, S Arikan‐Akdagli, J Bille, ... Clinical Microbiology and Infection 18, 9-18, 2012 | 463 | 2012 |
| Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A … E Durante-Mangoni, G Signoriello, R Andini, A Mattei, M De Cristoforo, ... Clinical infectious diseases 57 (3), 349-358, 2013 | 435 | 2013 |
| Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International … A Cometta, T Calandra, H Gaya, SH Zinner, R De Bock, A Del Favero, ... Antimicrobial agents and chemotherapy 40 (5), 1108-1115, 1996 | 388 | 1996 |
| Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification C Viscoli, O Varnier, M Machetti Clinical Infectious Diseases 40 (Supplement_4), S240-S245, 2005 | 383 | 2005 |
